Follicular progesterone elevations with ovulation induction for IVF
- PMID: 24841851
- DOI: 10.3109/09513590.2014.916263
Follicular progesterone elevations with ovulation induction for IVF
Abstract
The purpose of this review is to analyse the sources and effects of follicular progesterone elevations during ovarian stimulation, with the underlying mechanisms and preventive strategies on the in vitro fertilisation pregnancy outcome. In the early follicular phase, a flare-up effect of gonadotrophin releasing hormone (GnRH) agonists and incomplete luteolysis in GnRH antagonist regimens can result in significant elevations of progesterone. In the late follicular phase, progesterone elevations in GnRH analogue cycles are the result of the ovarian stimulation itself, driven by high follicle stimulating hormone dosage, estradiol levels, the number of follicles and oocytes. It seems that progesterone elevations (> or = 1.5 ng/mL or 4.77 nmol/L) have a detrimental effect on the outcome of pregnancy, accelerating the endometrial maturation. The most appropriate choice to avoid the negative effects of follicular progesterone elevations is to cancel fresh embryo transfer and to transfer frozen-thawed embryos in natural cycles. To prevent follicular phase elevations it might be preferable to use milder stimulation protocols, earlier trigger of ovulation in high responders and single-blastocyst transfer on day 5. The optimal GnRH analogue protocols during the entire stimulation period appear to be the long agonist as well as "long" and long GnRH antagonist regimens.
Keywords: Follicular progesterone elevation; IVF; ovarian stimulation; prevention.
Similar articles
-
Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.Hum Reprod. 2016 Aug;31(8):1859-65. doi: 10.1093/humrep/dew141. Epub 2016 Jun 14. Hum Reprod. 2016. PMID: 27301360
-
Is measurement of progesterone level prior to FSH stimulation useful in GnRH-antagonist cycles?Hum Fertil (Camb). 2015;18(4):234-7. doi: 10.3109/14647273.2015.1038658. Epub 2015 May 22. Hum Fertil (Camb). 2015. PMID: 25997693
-
GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels.Gynecol Endocrinol. 2013 Sep;29(9):843-5. doi: 10.3109/09513590.2013.808328. Epub 2013 Jun 26. Gynecol Endocrinol. 2013. PMID: 23802563
-
Preovulatory progesterone rise during ovarian stimulation for IVF.Gynecol Endocrinol. 2013 Aug;29(8):744-8. doi: 10.3109/09513590.2013.798280. Epub 2013 Jun 7. Gynecol Endocrinol. 2013. PMID: 23745784 Review.
-
Are GnRH antagonists comparable to agonists for use in IVF?Hum Reprod. 2007 Nov;22(11):2805-13. doi: 10.1093/humrep/dem270. Epub 2007 Sep 14. Hum Reprod. 2007. PMID: 17872909 Review.
Cited by
-
The Ideal Stimulation Protocol: Is There One?J Obstet Gynaecol India. 2015 Dec;65(6):357-61. doi: 10.1007/s13224-015-0723-8. Epub 2015 Jul 1. J Obstet Gynaecol India. 2015. PMID: 26663992 Free PMC article. No abstract available.
-
Letrozole Supplementation and the Increased Risk of Elevated Progesterone Levels on Trigger Day.Front Endocrinol (Lausanne). 2022 Jul 25;13:904089. doi: 10.3389/fendo.2022.904089. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35957830 Free PMC article.
-
Influence of human chorionic gonadotrophin during ovarian stimulation: an overview.Reprod Biol Endocrinol. 2020 Aug 6;18(1):80. doi: 10.1186/s12958-020-00639-3. Reprod Biol Endocrinol. 2020. PMID: 32762698 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources